Speaker Profile
Stefan Verheye

Stefan Verheye MD, PhD

Interventional Cardiology
Antwerpen, Antwerpen, Belgium

Connect with the speaker?

Dr. Stefan Verheye, MD, PhD, has been a senior interventional cardiologist at the Antwerp Cardiovascular Center, Antwerp Belgium since 2000. He is a member of the European Association of Percutaneous Cardiovascular Interventions, a member of the Belgian Working Group on Interventional Cardiology, and has been appointed as a Clinical Professor of Interventional Cardiology at the University of Brussels. He serves as a member of the Scientific Advisory Board of several medical device manufacturers. Dr. Verheye is the author of over 150 peer-reviewed journals (www.pubmed.com), ten book chapters, and over 400 abstracts, serves on the editorial board of the European Heart Journal – Digital Health and has led (as global principal investigator) and participated in numerous clinical (Phase I and II) and pre-clinical research studies in the field of innovative interventional cardiology (coronary artery disease, structural heart disease, heart failure). He has served as the medical director for V-Wave, Israel, a medical device company, developing and manufacturing inter-atrial shunts for heart failure. His entrepreneurial interests led to the co-foundation of Hilbert Paradox, NV, a start-up company encompassing a unique way of capturing and correlating digital health data, applying data- and knowledge engineering, which was later on acquired by a large CRO. He recently co-founded Amynas, BV a Belgian-based, incorporated technology platform company specializing in nanofiber electrospinning providing anti-infective and anti-inflammatory protection for implanted devices, including CIEDs, neuro-stimulatory, and orthopedic devices.

Stefan Verheye graduated from the School of Medicine at the University of Leuven in Belgium and was a resident in internal medicine and cardiology both at the University of Aachen, Germany, and OLV-Hospital, Aalst, Belgium. After a 2-year fellowship in interventional cardiology in Belgium, he completed a 2-year period as a research associate and visiting interventional cardiologist at the Andreas Gruentzig Cardiovascular Center at Emory University School of Medicine in Atlanta, Georgia, and served as an affiliate scientist, at the Division of Molecular Medicine for Yerkes Regional Primate Research Center of Emory University. He earned his PhD at the Department of Pharmaceutical Sciences of the University of Antwerp.

EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)